In Review: Last week, Wednesday, May 22, the House Insurance Committee held a hearing for sponsor testimony on HB 505 (community pharmacist/anti-PBM omnibus bill) and HB 384 (insulin cost cap). No votes were taken and no further hearings have been scheduled at this time.
The Ohio Coalition messaged the members urging them to share their concerns about the two bills that are receiving hearings. You can view that email communication here.
If you have any questions, please contact Sean Stephenson at sstephenson@pcmanet.org.
